Skip to main content
Top

Journal of Thrombosis and Thrombolysis

Issue 2/2008

Content (20 Articles)

Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16

Benjamin A. Olenchock, Stephen D. Wiviott, Sabina A. Murphy, Christopher P. Cannon, Nader Rifai, Eugene Braunwald, David A. Morrow

Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen

Sargis Khoobiar, Nicolai Mejevoi, Khalil Kaid, Catalin Boiangiu, Sampoornima Setty, Anjum Tanwir, Khaula Khalid, Marc Cohen

Platelet GPIbα, GPIV and vWF polymorphisms and fatal pre-hospital MI among middle-aged men

Minna Pellikka, Lassi Narhi, Markus Perola, Antti Penttila, Pekka J. Karhunen, Jussi Mikkelsson

Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation

Mehmet Polatli, Aysel Çakir, Orhan Cildag, A. Zahit Bolaman, Cigdem Yenisey, Yavuz Yenicerioglu

Higher morning serum cortisol level predicts increased fibrinogen but not shortened APTT

Giuseppe Lippi, Massimo Franchini, Gian Luca Salvagno, Martina Montagnana, Gian Cesare Guidi

Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days

Yuri B. Pride, Jacqueline L. Buros, Erin Lord, Matthew C. Southard, Caitlin J. Harrigan, Lauren N. Ciaglo, Marc S. Sabatine, Christopher P. Cannon, C. Michael Gibson

Changes in haemocoagulation in healthy volunteers after a 1-hour thrombotripsy using a diagnostic 2–4 MHz transcranial probe

David Školoudík, Táňa Fadrná, Michal Bar, Olga Zapletalová, Ondřej Zapletal, Jan Blatný, Miroslav Penka, Kateřina Langová, Petr Hluštík, Roman Herzig, Petr Kaňovský

Postmortem cardiac troponin-I levels predict intramyocardial damage at autopsy

Sara O. Vargas, Christine Grudzien, Milenko J. Tanasijevic

Underutilization of venous thromboemoblism prophylaxis in medical patients in a tertiary care center

Ramy Masroujeh, Wael Shamseddeen, Hussain Isma’eel, Zaher K. Otrock, Ismail M. Khalil, Ali Taher

Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome

Jovan Perunicic, Nebojsa M. Antonijevic, Predrag Miljic, Valentina Djordjevic, Danijela Mikovic, Mirjana Kovac, Milan Djokic, Igor Mrdovic, Aleksandra Nikolic, Zorana Vasiljevic

Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma

Giuseppe Lippi, Massimo Franchini, Gian Luca Salvagno, Martina Montagnana, Giovanni Poli, Gian Cesare Guidi

The lack of endothelization after drug-eluting stent implantation as a cause of fatal late stent thrombosis

Jozef Jakabčin, Marian Bystroň, Radim Špaček, Josef Veselka, Martin Kvašňak, Petr Kala, Jaroslav Malý, Pavel Červinka

Letter to the Editor regarding “Routine coagulation tests in newborn and infants”

Vera Ignjatovic, Fiona Newall, Robyn Summerhayes, Paul Monagle

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine